Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22390
Title: Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Agents, Phytogenic/adverse effects/*therapeutic use,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy,Female,Humans,Lung Neoplasms/*drug therapy,Male,Middle Aged,Paclitaxel/adverse effects/*analogs & derivatives/therapeutic use,*Taxoids
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22390
ISSN: 0007-0920
Link: http://www.ncbi.nlm.nih.gov/pubmed/7914429
http://www.nature.com/bjc/journal/v70/n2/pdf/bjc1994311a.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Cerny-1994-Docetaxel (Taxotere).pdf662.44 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons